Abstract
Liquid biopsy of cancers is an area of increasing interest in medical practice for the surveillance, management, and potential detection of malignant cells, using minimally invasive collection of body fluids. A liquid biopsy is particularly useful for metastatic cancers, which may be difficult to be sampled by core biopsy, due to difficulty of access or an occult location. Access to DNA shed from esophageal adenocarcinoma can enable the detection of mutations confirming the presence of malignant cells or the evolution of clonal lines with altered treatment response profiles. In this chapter, we detail a method for the isolation of cell-free DNA from blood plasma and DNA associated with exosomes in blood from patients with esophageal adenocarcinoma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gallerani G, Fabbri F (2016) Circulating tumor cells in the adenocarcinoma of the esophagus. Int J Mol Sci 17:1266
Boldrin E, Rumiato E, Fassan M, Balsamo L, Realdon S, Battaglia G, Rugge M, Amadori A, Saggioro D (2016) Liquid biopsy as a novel tool to monitor the carcinogenesis of Barrett's esophagus. Transl Res 2176:127–131
Feller SM, Lewitzky M (2016) Hunting for the ultimate liquid cancer biopsy – let the TEP dance begin. Cell Commun Signal 14:24
Alix-Panabières C, Pantel K (2013) Circulating tumor cells: liquid biopsy of cancer. Clin Chem 59:110–118
Brock G, Castellanos-Rizaldos E, Hu L, Coticchia C, Skog J (2015) Liquid biopsy for cancer screening, patient stratification and monitoring. Transl Cancer Res 4:280–290
Sclafani F, Smyth E, Cunningham D, Chau I, Turner A, Watkins D (2014) A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers. Clin Colorectal Cancer 13:94–99
Zhang J, Bowers J, Liu L, Wei S, Gowda GA, Hammoud Z, Raftery D (2015) Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One 7:e30181
Schmidt H, Kulasinghe A, Kenny L, Punyadeera C (2016) The development of a liquid biopsy for head and neck cancers. Oral Oncol 61:8–11
Kisiel JB, Konijeti GG, Piscitello AJ, Chandra T, Goss TF, Ahlquist DA, Farraye FA, Ananthakrishnan AN (2016) Stool DNA analysis is cost-effective for colorectal cancer surveillance in patients with ulcerative colitis. Clin Gastroenterol Hepatol 14:1778–1787
Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, Tu M, Garcia-Godoy F, Wong DT (2017) Saliva diagnostics – current views and directions. Exp Biol Med 242:459–472
Pan W, Gu W, Nagpal S, Gephart MH, Quake SR (2015) Brain tumor mutations detected in cerebral spinal fluid. Clin Chem 61:514–522
Ignatiadis M, Lee M, Jeffrey SS (2015) Circulating tumor cells and circulating tumor DNA: challenges and opportunities on the path to clinical utility. Clin Cancer Res 21:4786–4800
Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL (2014) Isolation of biologically-active exosomes from human plasma. J Immunol Methods 411:55–65
Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL (2005) Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 11:1010–1020
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Smith, R.A., Lam, A.K. (2018). Liquid Biopsy for Investigation of Cancer DNA in Esophageal Adenocarcinoma: Cell-Free Plasma DNA and Exosome-Associated DNA. In: Lam, A. (eds) Esophageal Adenocarcinoma. Methods in Molecular Biology, vol 1756. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7734-5_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7734-5_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7733-8
Online ISBN: 978-1-4939-7734-5
eBook Packages: Springer Protocols